September 19, 2018
Pfizer Inc. unit Wyeth and Teva Pharmaceuticals have fallen short in their bid to ax a proposed class action from end-payors alleging the companies engaged in a scheme to delay generic competition for antidepressant drug Effexor XR, with a New Jersey federal judge refusing to toss the case in its entirety.
October 24, 2013
A New Jersey federal judge on Tuesday said seven lawsuits alleging a pay-for-delay deal regarding Wyeth LLC's antidepressant Effexor XR can't continue until the U.S. Supreme Court decides whether it will hear a similar Third Circuit case involving blood pressure medication K-Dur.